- Muslim women break taboos navigating east London's waterways
- Nepal dam-building spree powers electric vehicle boom
- More than 60 dead from storm Helene as rescue, cleanup efforts grow
- Dozens missing, 9 dead in migrant boat wreck off Spanish Canaries
- Death toll from Hurricane John hits eight in Mexico
- Storm Helene's toll rises as rescue and cleanup efforts gain pace
- SpaceX launches mission to return stranded astronauts
- Storm Helene kills 44, threatens more 'catastrophic' flooding as cleanup begins
- SpaceX set to launch mission to return stranded astronauts
- Storm Helene kills 44, threatens more 'catastrophic' flooding
- Boeing strike grinds on as latest talks fail to reach agreement
- Iran 'news' sites, hackers target Trump ahead of US election
- US ports brace for potential dockworkers strike
- Japan's speedy, spotless Shinkansen bullet trains turn 60
- US hurricane deaths rise to 44, fears of more 'catastrophic' flooding
- Global stocks mostly rise, cheering Beijing stimulus
- Europe en route for Moon with new simulator, says astronaut Pesquet
- Fireworks forecast if comet survives risky Sun flypast
- Argentina judge orders dictionary to delete pejorative definition of 'Jewish'
- Global stocks rise on rate hopes, Beijing stimulus
- S.African woman turns 118, among the oldest in the world
- UK clears $4 bn AI partnership between Amazon, Anthropic
- Barca fans barred from Champions League away game over racist banner
- Chinese stocks extend surge, Europe higher on Beijing stimulus
- Pope says Church must 'seek forgiveness' for child sexual abuse
- China caps week of 'bazooka' stimulus for ailing economy with rate cut
- Cuts, cash, credit: China bids to jumpstart flagging economy
- France's debt weighs heavier ahead of budget debate
- Iran treads carefully, backing Hezbollah while avoiding war
- Return to sender: waste stranded at sea stirs toxic dispute
- 'Broken' news industry faces uncertain future
- On remote Greek island, migratory birds offer climate clues
- Taken from mother by nuns, victim seeks answers as pope visits Belgium
- China cuts amount banks hold in reserve to boost lending
- Hong Kong, Shanghai extend surge as China optimism boosts markets
- Vietnam president reiterates support for Cuba during official visit
- Drought reduces Amazon River in Colombia by as much as 90%: report
- Stay or go? Pacific Islanders face climate's grim choice
- Florida bracing for 'unsurvivable' Hurricane Helene
- Poverty rises to over 52 percent in Milei's Argentina
- Chloe's see-through look may not be for Kamala Harris
- Champagne houses abuzz over English sparkling wine
- Macron, Trudeau pledge to work for 'decarbonized' economies
- Hurricanes, storms, typhoons... Is September wetter than usual?
- China stimulus, tech optimism boost stock markets
- 'Unsurvivable' Hurricane Helene races towards Florida
- Macron meets Trudeau in Canada as both face political setbacks
- South Korea surges in UN innovation index
- Chloe's see-through look may not be for Kamala
- Floods threaten Niger's historic 'gateway to the desert'
All hormonal contraceptives increase breast cancer risk: study
All hormonal contraceptives carry a slightly increased risk of breast cancer, including the increasingly popular progestogen-only pills, according to a study published on Tuesday.
The researchers who carried out the study stressed that the increased risk of breast cancer needs to be weighed against the benefits of hormonal contraceptives, including the protection they provide against other forms of female cancer.
Previous studies have established an increased risk of breast cancer from two-hormone, or combined, contraceptives that use both estrogen and progestogen.
While the use of progestogen-only contraceptives has been on the rise for well over a decade, little research had been performed previously on their links to breast cancer.
The study, published in the journal PLOS Medicine, found that the risk of a woman developing breast cancer was about the same for hormonal contraceptives using both estrogen and progestogen as for those using just progestogen.
According to the study, women taking hormonal contraceptives have a 20 to 30 percent higher risk of developing breast cancer than those who do not use them.
The findings are similar to those published previously, including in a vast 1996 study.
The risk remains about the same regardless of the delivery method -- oral pill, IUD, implant or injection -- or whether it is a combined pill or progestogen alone.
Taking into account that the likelihood of breast cancer increases with age, the authors of the study calculated how much absolute excess risk is associated with hormonal contraceptives.
For women taking hormonal contraceptives for a period of five years between the ages of 16 to 20, it represented eight cases of breast cancer per 100,000, they said.
Between 35 and 39 years old, it was 265 cases per 100,000.
- 'Very small increase in absolute risk' -
"Nobody wants to hear that something that they're taking is going to increase their risk of breast cancer by 25 percent," said Gillian Reeves, a professor of statistical epidemiology at the University of Oxford and a co-author of the study.
"What we're talking about here is very small increase in absolute risk," Reeves said.
"These increases in risk for breast cancer have to, of course, be viewed in the context of what we know about the many benefits of taking hormonal contraceptives," she added.
"Not just in terms of birth control, but also because we know that oral contraceptives actually provide quite substantial and long term protection from other female cancers, such as ovarian cancer and endometrial cancer."
The study also confirmed, like others, that the risk of breast cancer declines in the years after a woman stops using hormonal contraceptives.
Stephen Duffy, a professor at Queen Mary University of London who did not take part in the study, described the findings as "reassuring in that the effect is modest."
The study involved data from nearly 10,000 women under the age of 50 who developed breast cancer between 1996 and 2017 in the United Kingdom, where the use of progestogen-only contraceptives is now as widespread as the combined method.
Reeves said there were several explanations for the growing use of progestogen-only contraceptives.
They are recommended for women who are breast-feeding, who may be at risk of cardiovascular problems or smokers above the age of 35.
"It might just be because women are taking hormonal contraceptives possibly into later years now," Reeves said.
"So they are naturally at higher risk of those other conditions for which risk is increased with combined contraceptives."
M.García--CPN